DERM

Conviction 55HealthcareScan · Mon, Aug 10, 2026

DERM$6.42-0.16%

ResistanceSupportVol 14

Vol MA14 254.83K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Journey Medical CorpPHARMACEUTICAL PREPARATIONSwww.jmcderm.com ↗

Price6.42

Change-0.16%

Gap+2.95%

Rel volume6.86×

Avg volume216.94K

Avg $ vol1.42M

SMA 206.66

SMA 506.55

SMA 2007.04

Price vs 50-2.02%

Price vs 200-8.82%

MA stackbearish

50/200 cross—

Supertrendup · 6.14

RSI (14)46

MACD hist-0.03

MACD cross—

Stoch %K / %D31 / 34

ADX (14)15

+DI / −DI18 / 18

RSI divergence—

MACD divergence—

ATR %+5.42%

ADR %5.25%

52w high9.26

52w low4.39

From 52w high-30.67%

Above 52w low+46.24%

New 52w highNo

SqueezeOff

Bollinger width23.16%

%B0.34

Donchian pos28.97%

Donchian high7.45

Donchian low6.00

AVWAP (52w high)6.30

vs AVWAP high+1.97%

AVWAP (52w low)6.03

vs AVWAP low+6.42%

OBV trendDown

Chaikin MF (20)-0.21

Today vs 20d6.86×

Avg vol (14d)254.83K

Avg vol (20d)216.94K

Avg $ vol (20d)1.42M

Market cap—

RS 3m (vs SPY)+22.90%

RS 6m (vs SPY)-37.11%

RS line new highNo

Trend template2/8

Technical rank21.5

1 week-0.77%

1 month-7.09%

3 months+26.63%

6 months-23.11%

1 year-12.05%

YTD-13.83%

P/E-6.48

P/B2.40

P/S1.21

P/FCF-2.70

EPS-0.4700

Div yield—

ROE-37.08%

ROA-12.49%

Debt/Eq0.82

Current1.72

EV/EBITDA-8.84

Gross margin—

Net margin-18.67%

Rev growth11.07%

EPS growth22.09%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value72.23M

Revenue15.92M

Net income-2.23M

Gross profit—

Free cash flow-27.44M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out21.53M

Employees58

ListedFri, Nov 12, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank21.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance7.40

Support5.92

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DERM

All disclosures →

No recent disclosed trades by Congress in DERM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DERM · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Toledano Miranda Jayne Director · Common Stock, $0.0001 par value · 2026-06-25	Grant	10K	—	2026-06-25	2026-06-29
Maraoui Claude President & CEO · Common Stock, $0.0001 par value · 2026-04-22	Grant	49.28K	$0	2026-04-22	2026-04-24
Alloush Ramsey Chief Operating Officer · Stock Option (Right to Buy) · 2026-04-22	Grant	62.8K	$0	2026-04-22	2026-04-24
Benesch Joseph CFO · Stock Option (Right to Buy) · 2026-04-22	Grant	41.86K	$0	2026-04-22	2026-04-24
Maraoui Claude President & CEO · Stock Option (Right to Buy) · 2026-04-22	Grant	82.92K	$0	2026-04-22	2026-04-24
Alloush Ramsey Chief Operating Officer · Common Stock, $0.0001 par value · 2026-04-22	Grant	46.86K	$0	2026-04-22	2026-04-24
Benesch Joseph CFO · Common Stock, $0.0001 par value · 2026-04-22	Grant	28.91K	$0	2026-04-22	2026-04-24

SEC filings

EDGAR filings in DERM · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.